Regional Analysis
Global Apheresis Equipment Market- Regional Insights
- North America is expected to be the largest market for apheresis equipment during the forecast period, accounting for over 40.5% of the market share in 2023. North America has dominated the global apheresis equipment market for many years due to a strong presence of leading players in the region. The U.S. is home to many large multinational companies, such as Haemonetics Corporation and Terumo BCT, which have a significant market share in blood component collection and therapeutic apheresis products globally. As per the International Trade Administration report published in January 2022, the U.S. medical technology industry exported goods worth US$ 44.5 billion in 2020. Apheresis equipment comprised a notable portion of these exports. Additionally, North America has a higher healthcare spend per capita as compared to other regions, enabling faster adoption of new and advanced apheresis technologies.
- Europe is expected to be the second-largest market for apheresis equipment, accounting for over 25.2% of the market share in 2023. The growth of the market in Europe is attributed to the rising prevalence of chronic diseases and favorable government initiatives in the region.
- Asia Pacific is expected to be the fastest-growing market for apheresis equipment, which is expected to grow at a CAGR of over 10.2% during the forecast period. The growth of the market in Asia Pacific is attributed to the large patient pool, increasing healthcare expenditure, and improving healthcare infrastructure in the region.
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East & Africa: GCC Countries, Israel, South Africa, North Africa, and Central Africa and Rest of Middle East
|
U.S.: 
U.K. : 
India : 
